Cargando…
High-throughput approaches for precision medicine in high-grade serous ovarian cancer
High-grade serous carcinoma (HGSC) is the most prevalent and aggressive subtype of ovarian cancer. The large degree of clinical heterogeneity within HGSC has justified deviations from the traditional one-size-fits-all clinical management approach. However, the majority of HGSC patients still relapse...
Autores principales: | Govindarajan, Meinusha, Wohlmuth, Christoph, Waas, Matthew, Bernardini, Marcus Q., Kislinger, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547483/ https://www.ncbi.nlm.nih.gov/pubmed/33036656 http://dx.doi.org/10.1186/s13045-020-00971-6 |
Ejemplares similares
-
Proteomics of High-Grade Serous Ovarian Cancer Models Identifies Cancer-Associated Fibroblast Markers Associated with Clinical Outcomes
por: Govindarajan, Meinusha, et al.
Publicado: (2022) -
The role of KIF14 in patient-derived primary cultures of high-grade serous ovarian cancer cells
por: Thériault, Brigitte L, et al.
Publicado: (2014) -
Molecular Profiling and Clinical Outcome of High-Grade Serous Ovarian Cancer Presenting with Low- versus High-Volume Ascites
por: Feigenberg, Tomer, et al.
Publicado: (2014) -
High Throughput Interrogation of Somatic Mutations in High Grade Serous Cancer of the Ovary
por: Matulonis, Ursula A., et al.
Publicado: (2011) -
Targeting the Microenvironment in High Grade Serous Ovarian Cancer
por: Nwani, Nkechiyere G., et al.
Publicado: (2018)